Clinical trials
Active, not recruiting Phase 1 Neuroblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baylor College of Medicine | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| Seattle Children's Hospital | 3 |
| New Approaches to Neuroblastoma Therapy Consortium | 2 |
| Cellectar Biosciences, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Mayo Clinic | 1 |
| National Cancer Institute (NCI) | 1 |
| St. Jude Children's Research Hospital | 1 |
| Stephan Grupp MD PhD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroblastoma | 21 |
| Osteosarcoma | 5 |
| Rhabdomyosarcoma | 5 |
| Sarcoma, Ewing | 5 |
| Sarcoma | 4 |
| Desmoplastic Small Round Cell Tumor | 3 |
| Hepatoblastoma | 3 |
| Recurrence | 3 |
| Rhabdoid Tumor | 3 |
| Sarcoma, Synovial | 3 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.